Domínguez Angela, Soldevila Núria, Toledo Diana, Godoy Pere, Espejo Elena, Fernandez Maria Amelia, Mayoral José María, Castilla Jesús, Egurrola Mikel, Tamames Sonia, Astray Jenaro, Morales-Suárez-Varela María
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.
Euro Surveill. 2017 Aug 24;22(34). doi: 10.2807/1560-7917.ES.2017.22.34.30602.
Influenza vaccination may limit the impact of influenza in the community. The aim of this study was to assess the effectiveness of influenza vaccination in preventing hospitalisation in individuals aged ≥ 65 years in Spain. A multicentre case-control study was conducted in 20 Spanish hospitals during 2013/14 and 2014/15. Patients aged ≥ 65 years who were hospitalised with laboratory-confirmed influenza were matched with controls according to sex, age and date of hospitalisation. Adjusted vaccine effectiveness (VE) was calculated by multivariate conditional logistic regression. A total of 728 cases and 1,826 matched controls were included in the study. Overall VE was 36% (95% confidence interval (CI): 22-47). VE was 51% (95% CI: 15-71) in patients without high-risk medical conditions and 30% (95% CI: 14-44) in patients with them. VE was 39% (95% CI: 20-53) in patients aged 65-79 years and 34% (95% CI: 11-51) in patients aged ≥ 80 years, and was greater against the influenza A(H1N1)pdm09 subtype than the A(H3N2) subtype. Influenza vaccination was effective in preventing hospitalisations of elderly individuals.
流感疫苗接种可能会限制流感在社区中的影响。本研究的目的是评估流感疫苗接种在预防西班牙65岁及以上人群住院方面的有效性。2013/14年和2014/15年期间,在西班牙的20家医院开展了一项多中心病例对照研究。将实验室确诊为流感而住院的65岁及以上患者,按照性别、年龄和住院日期与对照进行匹配。通过多变量条件逻辑回归计算调整后的疫苗效力(VE)。该研究共纳入728例病例和1826例匹配对照。总体疫苗效力为36%(95%置信区间(CI):22 - 47)。在无高危医疗状况的患者中,疫苗效力为51%(95%CI:15 - 71),在有高危医疗状况的患者中为30%(95%CI:14 - 44)。65 - 79岁患者的疫苗效力为39%(95%CI:20 - 53),80岁及以上患者为34%(95%CI:11 - 51),且对甲型H1N1pdm09流感亚型的效力比对甲型H3N2流感亚型的效力更大。流感疫苗接种在预防老年人住院方面是有效的。